cgp 20712a and mdl 100907

cgp 20712a has been researched along with mdl 100907 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Callebert, J; Etienne, N; Jaffré, F; Launay, JM; Maroteaux, L; Monassier, L; Nebigil, CG; Sarre, A	1
Baranowska, M; Kozłowska, H; Kozłowski, M; Malinowska, B; Schlicker, E	1

Other Studies

2 other study(ies) available for cgp 20712a and mdl 100907

Article	Year
Involvement of the serotonin 5-HT2B receptor in cardiac hypertrophy linked to sympathetic stimulation: control of interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha cytokine production by ventricular fibroblasts. Circulation, 2004, Aug-24, Volume: 110, Issue:8 Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Agonists; Animals; Cardiomegaly; Cells, Cultured; Drug Evaluation, Preclinical; Fibroblasts; Gene Expression Regulation; Heart Ventricles; Imidazoles; Indoles; Interleukin-1; Interleukin-6; Isoproterenol; Mice; Mice, Knockout; Myocytes, Cardiac; Propanolamines; Pyridines; Quinolines; Receptor, Serotonin, 5-HT2B; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Sympathetic Nervous System; Sympathomimetics; Tumor Necrosis Factor-alpha	2004
Potential involvement of a propranolol-insensitive atypical beta-adrenoceptor the vasodilator effect of cyanopindolol in the human pulmonary artery. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2006, Volume: 57, Issue:3 Topics: Adrenergic beta-Antagonists; Analysis of Variance; Bupranolol; Dose-Response Relationship, Drug; Female; Humans; Imidazoles; In Vitro Techniques; Male; Middle Aged; Pindolol; Pulmonary Artery; Receptor, Serotonin, 5-HT2A; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Serotonin 5-HT2 Receptor Antagonists; Vasoconstriction; Vasodilation; Vasodilator Agents	2006

Article

Year

Involvement of the serotonin 5-HT2B receptor in cardiac hypertrophy linked to sympathetic stimulation: control of interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha cytokine production by ventricular fibroblasts.

Circulation, 2004, Aug-24, Volume: 110, Issue:8

Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Agonists; Animals; Cardiomegaly; Cells, Cultured; Drug Evaluation, Preclinical; Fibroblasts; Gene Expression Regulation; Heart Ventricles; Imidazoles; Indoles; Interleukin-1; Interleukin-6; Isoproterenol; Mice; Mice, Knockout; Myocytes, Cardiac; Propanolamines; Pyridines; Quinolines; Receptor, Serotonin, 5-HT2B; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Sympathetic Nervous System; Sympathomimetics; Tumor Necrosis Factor-alpha

2004

Potential involvement of a propranolol-insensitive atypical beta-adrenoceptor the vasodilator effect of cyanopindolol in the human pulmonary artery.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2006, Volume: 57, Issue:3

Topics: Adrenergic beta-Antagonists; Analysis of Variance; Bupranolol; Dose-Response Relationship, Drug; Female; Humans; Imidazoles; In Vitro Techniques; Male; Middle Aged; Pindolol; Pulmonary Artery; Receptor, Serotonin, 5-HT2A; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Serotonin 5-HT2 Receptor Antagonists; Vasoconstriction; Vasodilation; Vasodilator Agents

2006